TY  - JOUR
AU  - Delgado, Juan F
AU  - Oliva, Juan
AU  - González-Franco, Álvaro
AU  - Cepeda, Jose María
AU  - García-García, Jose Ángel
AU  - González-Domínguez, Almudena
AU  - Garcia-Casanovas, Albert
AU  - Jiménez Merino, Silvia
AU  - Comín-Colet, Josep
PY  - 2020
DO  - 10.1080/13696998.2020.1838872
UR  - http://hdl.handle.net/10668/16445
T2  - Journal of medical economics
AB  - The treatment of iron deficiency (ID) with ferric carboxymaltose (FCM) improves the functional class and quality of life of chronic heart failure (CHF) patients with reduced left ventricular ejection fraction (LVEF), and reduces the rate of...
LA  - en
KW  - Budget impact
KW  - H51
KW  - I13
KW  - chronic heart failure
KW  - ferric carboxymaltose
KW  - heart failure
KW  - iron deficiency
KW  - Anemia, Iron-Deficiency
KW  - Ferric Compounds
KW  - Heart Failure
KW  - Humans
KW  - Iron
KW  - Maltose
KW  - Prospective Studies
KW  - Quality of Life
KW  - Spain
KW  - Stroke Volume
KW  - Ventricular Function, Left
TI  - Budget impact of ferric carboxymaltose treatment in patients with chronic heart failure and iron deficiency in Spain.
TY  - research article
VL  - 23
ER  -